Neutropenia
Neutropenia is a VA-ratable condition under diagnostic code 7702 in the Blood & Lymphatic System category. Maximum rating: 100%.
Rating Criteria
| Rating | Criteria |
|---|---|
| 100% | Requiring bone marrow transplant; **OR** infections recurring, on average, at least once every 6 weeks per 12-month period. |
| 60% | Requiring intermittent myeloid growth factors (granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) or continuous immunosuppressive therapy such as cyclosporine to maintain (ANC) greater than 500/microliter (µl) but less than 1000/µl; **OR** infections recurring, on average, at least once every 3 months per per 12-month period. |
| 30% | Requiring intermittent myeloid growth factors to maintain ANC greater than 1000/µl; **OR** infections recurring, on average, at least once per 12-month period but less than once every 3 months per 12-month period. |
| 10% | Requiring continuous medication (e.g., antibiotics) for control; **OR** requiring intermittent use of a myeloid growth factor to maintain absolute neutrophil count (ANC) greater than or equal to 1500/µl. |
Filing Tips
Pro Tip: The VA won't connect the dots for you. That's your job. Build the paper trail before you file.
Gather medical evidence showing a current diagnosis of this condition.
Document in-service events, injuries, or exposures that caused or aggravated this condition.
Consider a nexus letter from a medical professional linking your condition to service.
Review the rating criteria for DC 7702 to understand what symptoms warrant higher ratings.
Quick Links
Related Conditions
Acquired Agranulocytosis
DC 7702
Acquired hemolytic anemia
DC 7723
Acute Nonlymphocytic Leukemia
DC 7719
Addison's Anemia
DC 7722
Adenitis, tuberculous
DC 7710
Agranulocytosis
DC 7702
Agranulocytosis, acquired
DC 7702
Agranulosis
DC 7702